APA (7th ed.) Citation

DJ, S., H, B., J, H., X, M., C, M., K, N., . . . M, E. (2023). Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countries. Frontiers in pharmacology, 14, 1210579. https://doi.org/10.3389/fphar.2023.1210579

Chicago Style (17th ed.) Citation

DJ, Smith, et al. "Potential Pharmacokinetic Interactions with Concurrent Use of Herbal Medicines and a Ritonavir-boosted COVID-19 Protease Inhibitor in Low and Middle-income Countries." Frontiers in Pharmacology 14 (2023): 1210579. https://doi.org/10.3389/fphar.2023.1210579.

MLA (9th ed.) Citation

DJ, Smith, et al. "Potential Pharmacokinetic Interactions with Concurrent Use of Herbal Medicines and a Ritonavir-boosted COVID-19 Protease Inhibitor in Low and Middle-income Countries." Frontiers in Pharmacology, vol. 14, 2023, p. 1210579, https://doi.org/10.3389/fphar.2023.1210579.